| The global biotech industry is booming with an estimated market size of more than $300 billion, and emerging biotechs are driving a large portion of innovation and development. To learn more, download the whitepaper.
There are, however, many moving parts involved in developing a new drug, and just like an engine, all of them have to be present, working correctly, and in concert to keep a project moving forward. Drug development requires the coordinated efforts of a broad set of disciplines, including nonclinical, clinical, regulatory and commercial experts.
| |
